INTRODUCTION
Capping protein (CP) binds the barbed end of actin filaments and nucleates actin polymerization in vitro. Found in all eukaryotic organisms examined, CP is a heterodimer, with a and 13 subunits, each about 30-35 kDa . In striated muscle, CP, also known as CapZ, co-localizes with barbed ends of actin filaments at Z lines. During myofibrillogenesis, the interaction of CP with actin is essential for the proper assembly of actin filaments (Schafer et al., 1994) . In Dictyostelium, the binding of CP to barbed ends influences actin assembly and cell motility .
In addition to actin-binding, CP may possess other activities in vivo. Phosphoinositides inhibit the actinbinding activity of CP in vitro (Heiss and Cooper, 1991; , which is a poten-tial mechanism for coupling cell surface signals to changes in actin assembly and cell motility. CP forms a complex with hsc70 in Dictyostelium, which may affect its actin-binding activity (Eddy et al., 1993; Haus et al., 1993) . Also, CP localizes to the Z line independent of its ability to bind actin, indicating interactions with other proteins (Schafer et al., 1994) . In epithelial cells and yeast, CP localizes to sites of membrane-actin contact, suggesting that CP may mediate membrane attachment of actin Schafer et al., 1992) . Other actin-binding proteins are also present at these attachment sites and are also candidates to mediate the actin-membrane interaction (reviewed in Welch et al., 1994) .
To assess the function of CP both in vivo and in vitro, we chose the budding yeast Saccharomyces cerevisiae as a system for a structure-function analysis of CP. The a and 13 subunits of yeast CP, Mr 32 and 34 kDa, are encoded by the single genes CAPI and CAP2, respectively (Amatruda et al., 1990 . During the cell cycle, CP co-localizes with actin in cortical patches, which are clustered at the site of the emerging bud and remain polarized in the growing bud (Amatruda . CP is not associated with the cables of actin, which are found predominantly in the mother. Near the end of the cell cycle, the mother loses its cables and acquires more cortical patches, which also contain CP. Just before cytokinesis, a ring of actin cortical patches appears at the mother-bud neck; this dense structure does not stain with antibodies to CP , but does contain CP by fluorescence microscopy with a green fluorescent protein derivative of Cap2p (Waddle, Karpova, Waterston, and Cooper, unpublished data) . In addition, shmoos contain CP in association with the actin patches clustered at the shmoo tip . Therefore, CP may interact with actin or other components of the patch to effect actin function.
Null mutants of CAPI and/or CAP2 grow a bit slowly and have cell size heterogeneity, a severe deficit or complete absence of actin cables, and depolarization of the cortical actin patches . Loss of one CP subunit leads to loss of protein of the other subunit; therefore, single protein subunits are probably unstable and degraded in the absence of their heterodimer partners. While null mutants of CAPI and CAP2 are viable, the additional disruption of SAC6, a nonessential gene encoding the actin-binding protein fimbrin, is lethal (Adams et al., 1993) . We used these traits to assess CP function in vivo.
To investigate physiologic functions and their structural correlates for CP, we constructed a set of sitedirected mutations in CAPI and CAP2, which produce nested truncations and single and double amino acid changes in conserved hydrophilic residues of Caplp and Cap2p. One aim of this analysis was to identify regions essential for function in vivo and to determine whether substantial portions of the genes are not essential. In chicken CP, the C-terminal regions of the ,B subunit (Hug et al., 1992) and the a subunit (Casella and Torres, 1994) are necessary for actin binding in vitro. Therefore, we wished to test whether similar results would occur with yeast CP and what the in vivo consequences would be. In addition, certain evolutionarily conserved sequences were also targeted because they have a high likelihood for functional importance.
MATERIALS AND METHODS

Reagents and Supplies
Restriction enzymes, ligase, and all other DNA-modifying enzymes were obtained from Boehringer-Mannheim (Indianapolis, IN) . These were used with their accompanying commercial reaction buffers. Radioisotopes were obtained from Amersham (Arlington Heights, IL). Yeast culture media was obtained from BiolO1 (La Jolla, CA) . Otherwise, chemicals, solvents, and supplies were obtained from Sigma (St. Louis, MO) or Fisher (St. Louis, MO).
Molecular Biology and DNA Sequencing
Standard molecular biology techniques were employed (Sambrook et al., 1989) . Bacterial transformations were done according to the Hanahan standard competent cell method with XL1 blue Escherichia coli (Stratagene, La Jolla, CA), and all plasmids are resident in this strain. DNA was sequenced by the dideoxy chain termination method (Sanger et al., 1977) (Wada et al., 1992) . The identity of the products of the mutagenesis reactions were confirmed by sequencing with primers near the site of mutation. For oligonucleotide-mediated mutagenesis, in the initial phase of the work to test for in vivo function, several individual plasmids from each mutagenesis reaction were recovered and tested, to minimize the possibility that unintended mutations altered the phenotype. Later, if protein purification was performed, one plasmid was sequenced throughout its coding region to ensure that no unintended mutations had occurred.
Mutations of CAP1
For CAPI, nucleotide base numbers refer to GenBank/EMBL entry SCCAP1G, and amino acid residue numbers refer to SwissProt entry CAPA_YEAST. PstI/HaeII fragment of CAP2 (Amatruda et al., 1990) in the EcoRV site of pBS 071 PstI/BamHI fragment of CAP2 (Amatruda et al., 1990) in the PstI/BamHI sites of pBJ 080 (pRS314; Sikorski and Hieter, 1989) 
CAP1 XbaI/BamHI fragment of CAP2 (Amatruda et al., 1990) in the BamHI/XbaI sites of pBJ 082 (pRS 316; Sikorski and Hieter, 1989) 
PstI/BamHI fragment of CAP2 (Amatruda et al., 1990) Mutations that gave a loss of function in vivo, with protein present by immunoblot of whole-cell extracts, were also tested on a multicopy 2,u plasmid. The rationale was that because many of these mutations resulted in CP that was unstable during purification, we were concerned that the loss of function was due to a reduction in the cytoplasmic concentration of heterodimer. Therefore, we overexpressed the mutant protein to maximize the concentration of heterodimer. In these experiments, strains YJC 596 and 1070, which carry CAPI and CAP2 on URA3 CEN plasmids, were used to test capl and cap2 mutations, respectively. CEN plasmids were used to avoid possible recombination with the 2, plasmids being tested.
Fluorescence Microscopy
Actin was localized using rhodamine-phalloidin or using affinity-purified goat anti-yeast actin antibodies (Karpova et al., 1993) . Cells with cables were counted with a Zeiss Axiovert fluorescence microscope (Thornwood, NY) with a 10OX objective. CP was localized with affinity-purified rabbit anti-CP antibodies as described Proteins SDS-PAGE, immunoblots, and preparation of anti-yeast CP antibodies were as described . Acrylamide gels (10% or 12.5%) were used for SDS-PAGE. Gel-filtered actin from chicken pectoralis muscle was prepared and stored as described (Caldwell et al., 1989) . Actin buffer G was 2 mM Tris-HCl, pH 8.0, 0.2 mM ATP, 0.2 mM CaCl2, 0.1 mM dithiothreitol, 1 mM NaN3.
Partial Purification of CP
We felt that a partial purification was sufficient for these studies for several reasons. First, a systematic search of a yeast whole-cell extract for activities that decrease the low-shear viscosity of actin filaments has identified only two-cofilin (Moon et al., 1993) and CP . The initial anion exchange column in the purification procedure separates cofilin and CP well Moon et al., 1993) . Therefore, none of the observed activity should be due to contaminating cofilin. Second, for several mutants the purification procedure yielded either extensively proteolyzed or no CP, as detected by immunoblot. In these cases, no actin-binding activity was detected around the expected elution position of CP. Third, the specific activity of partially purified wild-type CP was identical to that of wild-type CP purified to homogeneity. Therefore, partially purified CP was not contaminated with other actin-binding activities.
Strains with plasmids carrying mutated forms of CP were grown to an OD6. of 6-8 in 2 liters of 2x SD medium with appropriate nutritional selection. Cells were harvested (typically 20 g wet weight), washed once in homogenization buffer (10 mM Tris/HCl, pH 8.0,10 mM EDTA, pH 8.0, 125 mM NaCl, 0.5 mM dithiothreitol, 340 mM sucrose), and suspended in an equal volume of homogenization buffer plus protease inhibitors (0.1 mM benzamidine, 1 mM phenylmethylsulfonyl fluoride, 1 ,ug/ml pepstatin A, 1 ,ug/ml leupeptin, 1 ,ug/ml aprotinin). Cells were disrupted using 0.5-mm glass beads in a bead-beater (Bio-Spec, Bartlesville, OK) with eight 1-min cycles separated by 1-min cooling periods. The bead-beater was jacketed in ice water, and all manipulations were done at 4°C. Cell lysis was monitored by phase microscopy and was >90% complete. After disruption, the beads were washed with an equal volume of homogenization buffer, and the wash was combined with the lysate.
Molecular Biology of the Cell
The cell lysate was spun at 12,000 x g for 10 min to remove glass beads and undisrupted cells. The supematant (-2 g total protein) was spun at 100,000 x g for 50 min. CP partitions to this supernatant under these conditions .
CP was then partially purified using two of the four column chromatography steps that were used previously to purify CP to homogeneity. The supernatant was removed, 0.2 ,gm filtered, and applied to a MonoQ HR16/10 column (Pharmacia Fine Chemicals, Piscataway, NJ) equilibrated in 10 mM Tris, pH 8.0, 1 mM EDTA, pH 8.0, 0.5 mM dithiothreitol, 1.5 mM NaN3. The column was eluted with a 300-ml linear gradient from 150 mM to 400 mM NaCl, and 5-ml fractions were collected. The fractions were rapidly analyzed by dot blots with rabbit anti-CP antibodies to identify fractions (typically 250-280 mM NaCl) containing CP. These fractions were pooled and applied to a 1.5 x 7 cm hydroxylapatite column (Bio-Gel HT, Bio-Rad, Hercules, CA) equilibrated in 10 mM KPO4, pH 7.0, 100 mM NaCl, 0.5 mM dithiothreitol, 1.5 mM NaN3. Protein was eluted with a 120-ml linear gradient to 250 mM KPO4, and 2-ml fractions were collected. Fractions containing CP (typically 50-60 mM KPO4) were identified with a dot blot as above, pooled, and concentrated 10-fold with a centricon-30 microconcentrator (Amicon, Beverly, MA). The OD280 of the final product was typically 1.3-1.5.
SDS-PAGE analysis of the pooled CP at various stages during the purification is shown in Figure 1 . The pool from the hydroxylapatite column (HAT pool) was used for activity assays. Both the MonoQ and hydroxylapatite columns provide appreciable degrees of purification. However, note that none of the Coomassie-stained bands in the region of CP are in fact CP, which was confirmed by highresolution side-by-side immunoblots with anti-CP and protein stains of the HAT pool and purified CP.
To calculate specific activity, the amount of CP in each sample was determined by a quantitative immunoblot of an SDS gel. The sample and a purified CP standard were serially diluted and ana- 
Actin-binding and PIP2 Inhibition Assay
To determine the specific activity of the partially purified protein, we quantified both the actin-binding activity and the amount of CP in the partially purified material. CP purified to homogeneity was used as a standard in both determinations. Actin-binding activity was measured by inhibition of low-shear viscometry of actin filaments (Pollard and Cooper, 1982) , and the amount of CP was measured by quantitative immunoblots.
In the low-shear (falling ball) viscometry assay, 50 Al of 0.25 mg/ml chicken skeletal muscle G-actin in buffer G was incubated with 125 jl sample in MKEI (2 mM MgCl2, 100 mM KCl, 1 mM EGTA, 20 mM imidazole, pH 7.0) for 20 min before apparent viscosity was determined as the time for the ball to roll 10 cm. Each sample of CP was serially diluted over the concentration region that gave a 50% decrease in apparent viscosity. Wild-type CP purified to homogeneity from an overexpression strain as described was used as the standard, and serial dilutions were assayed under conditions identical to those for the mutant CP. Inhibition of CP activity by PIP2 was also measured by low-shear viscometry, as described (Heiss and Cooper, 1991) . CP was dialyzed into buffer B (10 mM Tris-HCl, pH 8.0, 50 mM KCI, 1 mM 2-mercaptoethanol, 1 mM NaN3, 0.5 mM EDTA, 0.1 mM phenylmethylsulfonyl fluoride). The reaction buffer was MKEI without MgCl2 and EGTA.
Calorimetry
Differential scanning calorimetry was performed with a MicroCal MC-2 calorimeter (MicroCal, Northampton, MA) in the Department of Biochemistry and Molecular Biophysics at Washington University. Wild-type CP, purified from the overexpression strain , was present at 1-2 mg/ml in buffer B. Samples were heated at a rate of 60°/h to a preset temperature, cooled, and heated again.
Sequence Analysis
The program MACAW, v.2.03 for Mac68K, was used to search for blocks of sequence similarity (Schuler et al., 1991) . The segment pair overlap method was used with BLOSUM 62 and PAM120. The sequences were the protein sequences of the a and ,B subunits of CP from chicken, nematode, Dictyostelium, and yeast (Waddle et al., 1993) .
RESULTS
Strategies for Choosing Site-directed Mutations
The first strategy was to truncate each protein from each end to attempt to identify portions of the protein not necessary for function in vivo. The second was to make charge changes in evolutionarily conserved hydrophilic residues, especially clusters of basic residues, which are important for binding actin in other proteins (Friederich et al., 1992) . This strategy was Vol. 7, January 1996 successful in site-direction mutagenesis of actin (Wertman et al., 1992) . The third was to make charge changes in regions conserved in both a and ,B subunits, to test the hypothesis that each subunit binds in a similar fashion to each protofilament of actin.
Scheme for Evaluation of Site-directed Mutations The scheme was to introduce a site-directed mutation in one of the genes for CP, CAP1 or CAP2, and then test the ability of the mutant gene to function in vivo, i.e., to rescue traits or features of the null mutant phenotype. These traits included decreased growth rate, the absence of actin cables, depolarization of actin cortical patches, loss of localization of CP to actin cortical patches (Amatruda et al., 1990 , and inviability in a sac6 background (Adams et al., 1993; Karpova et al., 1993) . Depolarization of actin cortical patches always correlated with loss of actin cables. Depolarization was difficult to define and therefore score and quantitate reproducibly; thus, we only quantitated the presence of cables and noted patch depolarization qualitatively.
We identified and excluded from extensive additional analysis mutations that led to the absence of CP by determining the level of CP in a whole-cell extract by immunoblot. Because each subunit needs the other for stability, this determination also excluded mutations that altered protein folding. As expected, in all cases in which the level of CP was severely decreased, the mutation did not rescue any aspect of the null phenotype.
CP from mutants that displayed significant cellular levels of CP was tested for actin-binding and inhibition by PIP2. Mutant CP was partially purified from strains that carried the mutated gene on a low-copy number plasmid and whose chromosomal copy of that gene was deleted. The protein is only stable as a heterodimer, so the mutant subunit co-purified with its wild-type counterpart.
Presentation of Data
The immunoblot analysis to detect CP for all the mutations is shown in Figure 2 . Representative immuno- Figure 3 and rhodamine-phalloidin fluorescence images of actin distribution are shown in Figure 4 : The data for growth rate, formation of actin cables, and sac6 viability are presented in Table 3 , which also tabulates all the immunoblot and immunofluorescence results. Note that actin cable formation was quantitated by looking through the microscope and counting many cells. The images in Figure 4 include just a few selected cells, and long exposures were chosen to demonstrate fine detail. These results together with additional data are discussed in terms of different sections of the protein targeted for mutagenesis, as follows. Figure 5 is a diagram illustrating the locations of the mutations.
The N-Terminus of the a Subunit (Caplp) Two N-terminal deletion mutations of Caplp, A2-21 and A2-37 ( Figure 5A ), led to severe and complete absence, respectively, of cellular CP by immunoblot of whole cell extracts ( Figure 2 ) and by immunofluorescence (Table 3 ). Both mutations led to absence of function in vivo by tests for actin cables, sac6 viability, and growth rate (Table 3) . Caplp has a total of 268 amino acid residues. Therefore, in this region, a very small truncation (20/268 residues, 7%) led to a severe loss of protein in vivo.
The C-Terminus of the a Subunit (Caplp) Two deletion mutations in a region of conserved sequence near the C-terminus of Caplp were analyzed ( Figure 5B ). First, residues 239-264 were deleted and replaced with Thr. Second, residues 225-264 were deleted and replaced with Pro. Each mutant protein still includes residues 265-268, so these are not truncations but rather deletions very near the C-terminus. The smaller deletion, A239-264, gave a moderately reduced level of CP in whole cell extracts (Figure 2) . In vivo function, tested by growth rate, actin cables, and sac6 viability, was lost completely, and the CP immunofluorescence distribution was diffuse and of low intensity (Table 3) (Table 3 ).
The region defined by the smaller deletion included two conserved Arg residues, and clusters of basic residues have been implicated in actin-binding sites (Friederich et al., 1992) . Therefore, we mutated the two conserved Arg residues, 239 and 240, to Glu ( Figure  5B ). This mutant protein was stable by immunoblot, with loss of function in vivo by all three tests ( Figure   4 and Table 3 ). The CP immunofluorescence was diffuse and intense (Figure 3) . Partial protein purification of both mutants, A239-264 and RR239,240EE, was attempted, but no CP was recovered, based on immunoblots. Parallel purification of wild-type and other mutant CPs was successful, as discussed below; therefore, these two mutant CPs may be unstable or highly susceptible to protease.
To test the hypothesis that decreased protein stability led to insufficient levels of heterodimer for the A239-264 and RR239,240EE mutants, we determined whether overexpression of the mutant proteins would rescue the phenotype. We reasoned that increasing the expression of the mutant subunit would increase the concentration of heterodimer and might thereby produce function. On the other hand, if the mutation truly leads to a heterodimer that itself is nonfunctional, then increasing expression of the mutant subunit should have no effect. The mutated genes were placed on high-copy number plasmids, which did produce increased levels of proteins, as documented by immunoblot ( Figure 6 ). Compare the lanes labeled "H" in Figure 6 with lanes labeled "L" for the wild-type. In each case, the levels of the mutant proteins are at or above the wild-type level. For the A239-264 and RR239,240EE mutants, overexpression still showed loss-of-function in vivo (Table 4) . Therefore, we conclude that this region near the C-terminus of Caplp, including the Arg residues of 239 and 240, is essential . Cable formation is severely decreased, and patches are polarized poorly. cap2-8 RR14,15EE is the one mutant whose only defect is a partial loss of cables as detected by an observer looking through a microscope and counting cells with cables. That defect is not readily appreciated from the long-exposure images of the few cells here. cap2-9 L161 is like wild type. Bar, 10 ,um.
sized might be important for function. Two mutations, Q5K and RR14,15EE, were tested ( Figure 5C ). As above, the pair of conserved Arg residues was targeted because clusters of basic residues have been implicated in actin-binding sites in other proteins (Friederich et al., 1992) . Both mutations had protein by immunoblot and were functional in vivo by tests of growth rate and sac6 viability (Figures 2 and 3 ; Table  3 ). Q5K showed complete rescue of actin cables (81% ,  Table 3 ). However, RR14,15EE had only a partial rescue of cables (28%, (Hug et al., 1992) . In that work, truncation of the C-terminus of the f31 subunit by 12 amino acid residues led to a loss of actin-binding. The primary structure of this region of the protein is remarkable because it is the only region, throughout the sequences of both a and f subunits, that is not conserved across species (Waddle et al., 1993) . In addition, this region is the only difference between the 131 and f2 isoforms of vertebrates, which have different subcellular distributions (Schafer et al., 1994) . Therefore, we hypothesized that this region is not the actinbinding site, but rather a structural element necessary for actin-binding.
Because of the lack of sequence conservation between chicken and yeast in this region, we could not choose a mutation directly analogous to the 12-residue truncation of the chicken 31 subunit, therefore, we made truncations of 11, 21, 31, and 43 amino acids ( Figure 5D ). Truncations of 11, 21, and 31 residues yielded mutant CP that did function in vivo by tests of growth rate, actin cables, and sac6 viability, and retained a wild-type CP immunofluorescence distribution (Table 3) . Additional tests for sac6 viability at different temperatures and at high osmolarity also showed complete rescue. Mutant CP was partially purified for the 21-residue truncation.
In contrast to the prediction from the chicken CP results (Hug et al., 1992) , the actin-binding activity of the mutant CP was identical to that of wild-type CP ( Figure 7B ). The actin-binding activity was inhibited by PIP2, as observed for wild-type CP (Table  5) . Purification of the 31-residue truncated protein yielded CP that was extensively proteolyzed by immunoblot and inactive by falling ball viscometry.
The 43-residue truncation showed loss of function in vivo, for growth rate, actin cables, and sac6 via- Each diagram shows the predicted amino acid sequence of the CAPI or CAP2 gene, labeled Caplp or Cap2p, respectively. * indicates a stop codon. Residues on the line labeled "Conserved" are found in all CP sequences, including yeast, Dictyostelium, nematode, and chicken (Waddle et al., 1993) . Gray bars indicate the deleted amino acid residues, and allele names are indicated on the right side. For point mutations, the result of the mutation is indicated in the line labeled "Point Mutants," under the main amino acid sequence, with allele names undemeath. bility ( Figure 4 and Table 3 ). The level of CP by immunoblot of a whole cell extract was moderately decreased, and the CP immunofluorescence distribution was diffuse and weak (Figures 2 and 3 ; Table  3 ). Overexpression still gave loss-of-function (Table  4 ) despite increased levels of protein (Table 4) . No CP was recovered from attempts to purify this mutant protein. A mutation of a conserved hydrophilic residue in this region, K252E ( Figure 5D ), functioned in vivo and had a wild-type CP immunofluorescence distribution (Table 3) .
Therefore, we conclude that the region between residues 245 and 257, but not residue 252 alone, is essential for function, and that all assayed functions-actin cables, sac6 viability, and CP localization to actin cortical patches-are lost together. Region of a/13 Similarity One hypothesis for how CP binds to and caps the barbed end of the actin filament is that each subunit of CP, a and ,B, binds to the terminal protomer of one of the two protofilaments. Perhaps each CP subunit even binds to the same site on the actin molecule because each subunit contains the same actin-binding motif. However, the primary sequences of the a and f3 subunits of capping are not similar to each other and do not contain known actin-binding motifs found in other proteins (Am- , 1990, 1992) . MACAW, a program that detects blocks of sequence similarities (Schuler et al., 1991) , was challenged to align simultaneously the complete sequence of the a and ,3 subunits from four organisms. The block shown in Figure 9 had the greatest statistical significance (P = 2 x 10-14). To test the importance of these regions, we reversed the charge of a conserved charged residue in each subunit. The a subunit, E188K capl-5, showed loss of function in vivo, stable protein by immunoblot, and a diffuse immunofluorescence distribution (Figures 2  and 4 ; Table 3 ). Placing the mutation on a multicopy plasmid gave increased expression ( Figure 6 ) but still showed loss of function (Table 4) . Therefore, this mutation identifies a third essential region, and all functions are lost together, as in the other two essential regions. Purification of this mutant protein was attempted but no CP was recovered.
On the other hand, a similar mutation in the 13 subunit, E119K cap2-6, showed normal function in vivo and a wild-type immunofluorescence distribution ( Figure 2 and Table 3 ). The partially purified protein had normal actin-binding activity ( Figure 7C ) and was inhibited by PIP2 (Table 5) .
Therefore, the hypothesis as presented above is not confirmed, in the sense that this single region of similarity does not represent two actin-binding sites, one in a and one in 03, both of which are necessary for binding. CP (Adams et al., 1993; Karpova et al., 1993) , and with some point mutations of ACTI, which encodes actin (Karpova et al., 1995) . Another possible molecular interaction is binding and inhibition by PIP2. This interaction occurs in vitro Heiss and Cooper, 1991) These mutations are not informative for this analysis, which requires that the mutant protein be present in the cell.
Number of Regions Essential for Function
Mutations that give loss of function in vivo and preserve the presence of protein identify four different regions of the primary structure necessary for CP function. The first is the C-terminal portion of the ,B subunit, Cap2p, identified by a small truncation. The second is the C-terminal region of the a subunit, Caplp, identified by a double charge-change point mutation in two conserved residues and a small deletion. The third is the interior of the a subunit, defined by a charge-change point mutation in a conserved residue, Glu188Lys. The fourth is the N-terminal region of Cap2p, identified by a double charge-change point mutation in two conserved residues, Argl4Glu and Argl5Glu.
Mutations in the first three regions led to a complete loss of all cellular aspects of CP function-growth rate, formation of actin cables, polarization of cortical actin patches, sac6 viability, and localization of CP to cortical actin patches. The mutation in the fourth region caused a deficit only in the actin distribution, including formation of cables and polarization of patches, and that deficit was partial, not complete.
Some of these mutations also led to a decreased level of CP in vivo, so we were concerned about the possibility that loss of function was secondary to a reduced level of protein instead of reflecting the function of the affected region of the protein. To address this possibility, the mutant proteins were overexpressed and achieved levels equal to or greater than those of wildtype CP. In each of the four cases, including the mutation with only a partial deficit in actin distribution, we saw no increase in the level of function in vivo upon overexpression. Therefore, we conclude that the effects of the mutations do reflect the properties of the relevant region of the protein and not simply a destabilization of the protein overall.
Number and Nature of Molecular Interactions The first question for interpreting these results is how many molecular interactions are revealed? If the mutations in the four different regions were each associated with a different constellation of phenotypic traits, then the interpretation would be four different molecular interactions. This was the case for a mutational analysis of calmodulin in yeast (Ohya and Botstein, 1994) . However, the results here are that the mutations in three different regions show the same constellation of phenotypic traits, which are the same as and include all those seen in a null mutant. These results do not support the existence of multiple molecular interactions and can be explained most simply by a single molecular interaction. Next, the constellation of traits associated with the fourth region is a subset of the larger group of traits. There are two main possible interpretations of this result. First, there may be multiple molecular interactions and this fourth region may be important for only one interaction while the other three regions are important for all molecular interactions. Second, there may be only one molecular interaction, and mutation of this fourth region only causes a loss of a portion of that interaction, while mutations in the other three regions cause a complete loss of the interaction. An explanation for only some traits being affected by the mutation of the fourth region is that these traits are more sensitive indicators of the interaction.
Without additional evidence, we prefer the more conservative interpretation of one molecular interaction because it is the simplest model that explains all the results. Additional experimentation might help discriminate between these models. First, testing more mutants would help to choose between the two interpretations, by providing either more results like those already obtained or by providing evidence for different constellations of traits. Second, an atomic structure of capping protein would indicate whether the four regions were in the same or different places in the tertiary structure. This analysis has an important limitation, however, which has been observed in studies of actin mutants. Mutations that affect one area of the three-dimensional structure of actin can have allosteric effects on distant regions (reviewed in Egelman and Orlova, 1995) . Because the calorimetry analysis here indicates that CP is a single domain, the possibility for such allosteric effects is higher.
The second question for interpreting these results, assuming the single molecular interaction model, is what is the nature of that molecular interaction? The obvious candidate is binding to actin filaments for Vol. 7, January 1996 several reasons. CP binds actin filaments in vitro with high affinity, CP co-localizes with actin filaments in cells, and CP interacts genetically with actin. One aspect of the results here supports that interpretation. Mutant CP showed a diffuse localization in the cell, instead of localizing to the patches of actin filaments. The mutants still had patches of actin filaments, so the mutant CP did not bind to those actin filaments in vivo. The best test of this hypothesis would be whether the mutant CPs bind to actin in vitro, using purified proteins. Unfortunately, our attempts to purify the relevant mutant CPs were unsuccessful, despite a wide variety of technical maneuvers. The proteins were proteolyzed or unstable during the purification process. We were able to purify two mutant CPs that showed normal function in vivo. They bound actin normally, which does support this hypothesis.
Comparison to Results with Chicken CP The sequence of CP is well conserved across species (Waddle et al., 1993) , and CP from nematode (Waddle et al., 1993) and Drosophila (Hopmann, Cooper, and Miller, unpublished data) is able to function in yeast, rescuing the null phenotype. The results here include one interesting discrepancy in comparing how yeast and chicken CP function to bind actin in vitro. At the C-terminal region of the CP ,B subunit, a 43-residue truncation was not functional in vivo, but truncations of 11, 21, and 31 residues were functional. Purified CP with the 21-residue truncation bound actin normally. On the other hand, with chicken CP (31, a 12-residue truncation caused loss of actin-binding in vitro (Hug et al., 1992) and a loss of function, consistent with loss of actin binding, in vivo during myofibrillogenesis (Schafer et al., 1995) . A possible explanation for the difference between yeast and chicken proteins, especially because the 43-residue yeast truncation mutant was not functional in vivo, is that the C-terminal region is not the actin-binding site per se, but rather an element adjacent to the actin-binding site and essential for its structure. The yeast and chicken proteins might then simply differ in the extent of deletion necessary to destabilize that structure. Alternatively, this actinbinding site may exist in chicken muscle CP but not yeast CP, enabling stronger binding by the chicken CP.
The second essential region is the C-terminal region of the a subunit, Caplp, where deletion of 45 residues causes loss-of-function, with presence of protein. In addition, mutation of two conserved Arg residues to Glu in this region also leads to loss of function. With chicken CP, deletion of 55 residues at the C-terminus of the a-subunit causes a loss of actin binding in vitro (Casella and Torres, 1994) . So in this case, loss of function in vivo with yeast CP does correlate with loss of actin binding in vitro with chicken CP.
Instability of Mutant CPs
Complete loss of one CP subunit leads to a loss of the other subunit in vivo ). Here we found that relatively small deletions at either end of either subunit of CP lead to a loss of protein in vivo and that CP behaves as a single domain by calorimetry. Therefore, the two subunits depend heavily on each other for their stability, which can be compromised by relatively minor perturbations. These results in vivo present an interesting contrast with results in vitro using chicken CP prepared by in vitro translation. In those studies, much more extensive deletions were compatible with the subunits binding to each other tightly enough to be purified by gel-filtration chromatography at relatively low protein concentrations (Casella and Torres, 1994) . This difference between in vivo and in vitro results suggests that in vivo short truncations are sufficient to target the protein for degradation. This degradation must be rapid and complete because proteolysis of the subunits in the immunoblots of the whole cell extracts was not observed, just the absence of protein. Further analysis of the mechanism of this degradation may provide insight into normal mechanisms of protein turnover.
